Neuberger Berman Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$448K Buy
7,556
+2,631
+53% +$171K ﹤0.01% 1677
2025
Q4
$304K Buy
4,925
+96
+2% +$5.88K ﹤0.01% 1800
2025
Q3
$301K Sell
4,829
-351
-7% -$24.4K ﹤0.01% 1754
2025
Q2
$414K Buy
5,180
+121
+2% +$10.1K ﹤0.01% 1641
2025
Q1
$435K Buy
5,059
+1,126
+29% +$92.4K ﹤0.01% 1560
2024
Q4
$307K Sell
3,933
-121,571
-97% -$9.44M ﹤0.01% 1662
2024
Q3
$9.05M Buy
125,504
+2,374
+2% +$168K 0.01% 819
2024
Q2
$8.48M Buy
123,130
+9,265
+8% +$628K 0.01% 799
2024
Q1
$8.26M Buy
113,865
+25,202
+28% +$1.69M 0.01% 821
2023
Q4
$5.43M Buy
88,663
+19,547
+28% +$1.16M ﹤0.01% 891
2023
Q3
$3.95M Buy
69,116
+565
+0.8% +$34.1K ﹤0.01% 931
2023
Q2
$4.07M Buy
68,551
+64,218
+1,482% +$3.84M ﹤0.01% 932
2023
Q1
$271K Sell
4,333
-4,639
-52% -$290K ﹤0.01% 1633
2022
Q4
$562K Buy
8,972
+3,364
+60% +$193K ﹤0.01% 1411
2022
Q3
$280K Buy
5,608
+1,556
+38% +$86.2K ﹤0.01% 1633
2022
Q2
$238K Buy
+4,052
New +$223K ﹤0.01% 1710
2018
Q2
Sell
-1,496,553
Closed -$50.5M 1739
2018
Q1
$50.5M Sell
1,496,553
-44,735
-3% -$1.72M 0.06% 405
2017
Q4
$68.4M Buy
1,541,288
+205,500
+15% +$9.36M 0.08% 348
2017
Q3
$66.9M Buy
1,335,788
+925
+0.1% +$47.3K 0.08% 331
2017
Q2
$70.5M Sell
1,334,863
-55,371
-4% -$2.97M 0.09% 313
2017
Q1
$77.2M Sell
1,390,234
-9,695
-0.7% -$535K 0.1% 301
2016
Q4
$72.9M Sell
1,399,929
-48,200
-3% -$2.33M 0.1% 304
2016
Q3
$69.9M Buy
1,448,129
+218,400
+18% +$11M 0.09% 304
2016
Q2
$68.1M Buy
1,229,729
+1,188,623
+2,892% +$65.5M 0.09% 293
2016
Q1
$2.19M Buy
+41,106
New +$2.02M ﹤0.01% 965

Other funds holding PBH

Neuberger Berman Group's PBH Position: Q1 2026 in Review

Neuberger Berman Group increased its Prestige Consumer Healthcare (PBH) stake by 53% in Q1 2026, buying an estimated $171K and bringing the position to 7,556 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Neuberger Berman Group first reported a position in PBH in Q1 2016 and has held it in 25 quarters since. The position peaked at $77.2M in Q1 2017. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Neuberger Berman Group held 7,556 shares of Prestige Consumer Healthcare worth $448K as of Q1 2026.
  • Neuberger Berman Group bought 2,631 Prestige Consumer Healthcare shares in Q1 2026, an estimated $171K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1677 holding.
  • Neuberger Berman Group first reported a position in Prestige Consumer Healthcare in Q1 2016 and has held it in 25 quarters since.
  • Neuberger Berman Group's Prestige Consumer Healthcare position peaked at $77.2M in Q1 2017.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.